Ed Scolnick

Ed Scolnick

Direktor/Vorstandsmitglied bei
Massachusetts Institute of Technology
85 Jahre
Health Technology
Commercial Services
Finance

Profil

Ed M.
Scolnick
is currently the Director at Massachusetts Institute of Technology, and a Member of the National Academy of Sciences, American Academy of Arts & Sciences, and National Academy of Medicine.
He previously served as Director at EMD Millipore Corp., Renovis, Inc., Hypnion, Inc., Link Medicine Corp., and Chiasma, Inc. He was also a Director at Alnylam Pharmaceuticals, Inc. from 2008 to 2010.
Additionally, he served as Senior Vice President-Cell Biology Research at Merck & Co., Inc. from 1982 to 2002, and as President of Merck Research Laboratories Massachusetts LLC from 1982 to 2003.
He was also a Director at the US Food & Drug Administration and National Cancer Institute.
Dr. Scolnick received his undergraduate degree in 1961 and doctorate in 1965 from Harvard University.

Aktive Positionen von Ed Scolnick

UnternehmenPositionBeginn
Direktor/Vorstandsmitglied -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -

Ehemalige bekannte Positionen von Ed Scolnick

UnternehmenPositionEnde
Direktor/Vorstandsmitglied 15.07.2010
ALNYLAM PHARMACEUTICALS, INC. Direktor/Vorstandsmitglied 01.02.2010
Private Equity Investor 30.06.2008
Direktor/Vorstandsmitglied 20.07.2005
Präsident 01.01.2003
Sehen Sie sich die Erfahrung von Ed Scolnick im Detail an

Ausbildung von Ed Scolnick

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

93

Beziehungen ersten Grades

17

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen17

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Finance

Consumer Services

Health Technology

Finance

Health Services

Miscellaneous

Government

Commercial Services

Commercial Services

Commercial Services

Health Technology

  1. Börse
  2. Insiders
  3. Ed Scolnick
-40 %: Exklusive Verlängerung
T
:
:
PROFITIEREN SIE JETZT